A spin-out from Manchester University, Manchester Imaging, has successfully raised £600,000 to advance its pioneering software aimed at early detection of tooth decay.
This funding is set to facilitate the development and commercial launch of their software products, employing cutting-edge machine learning and computer vision technologies.
Manchester Imaging secured £600,000 from GM&C Life Sciences Fund, Catapult Ventures, and NPIF – Mercia Equity Finance. This substantial investment underscores the confidence in Manchester Imaging’s vision and innovative approach.
The funds will be utilised to enhance and introduce the company’s suite of software solutions capable of detecting early signs of tooth decay with unparalleled precision. The strategic financial backing is aimed at pushing the boundaries in dental diagnostics.
Manchester Imaging is employing machine learning and computer vision processes to develop software capable of identifying early tooth decay stages.
This groundbreaking technology has the potential to revolutionise dental care by enabling earlier intervention and the use of preventative treatments, ultimately reducing the need for fillings.
CEO Tony Travers expressed enthusiasm over the collaboration with Catapult Ventures and Mercia Fund Managers.
He emphasised the critical impact their software, CARIESDENT, will have in dental practice, aligning with their mission to support both dentists and patients.
Through this partnership, Manchester Imaging aims to establish itself as a frontrunner in dental diagnostic imaging solutions.
In conjunction with the funding, Kevin D’Silva, a venture partner at Catapult Ventures, joins the board as a non-executive chairman.
This strategic appointment is poised to strengthen Manchester Imaging’s governance and drive its mission forward.
Manchester Imaging’s leadership remains focused on advancing dental diagnostics.
With a highly experienced team, they are committed to elevating the standards of dental care through technology-driven solutions.
Their strategic approach is designed to ensure long-term success and industry leadership.
Dr Mark Wyatt of Mercia Fund Managers expressed confidence in Manchester Imaging’s trajectory, highlighting the capability of its leadership team.
Having previously supported the company, Mercia Fund Managers continues to endorse this promising venture.
With substantial backing, Manchester Imaging is well-positioned to capture a significant market share in the dental diagnostics arena.
Manchester Imaging’s advancements in dental technology represent a significant step forward in healthcare innovation.
With the new funding and strategic leadership, the company is on a promising path to becoming a leader in dental diagnostics.
Manchester Imaging’s recent funding marks a pivotal moment in its growth, underscoring its potential impact on dental care innovation.
The combination of cutting-edge technology, robust leadership, and strategic investment bodes well for the future of dental diagnostics.
